CVS Health (NYSE:CVS) announces a quarterly dividend of $0.50



CVS Health (NYSE:CVS) to go ex-dividend.
On 3/6/2019 CVS Health ( NYSE:CVS ) announced that it will be issuing a quarterly dividend in the amount of $0.50 down from $0.50 making the yield 3.69%.


CVS Health (NYSE:CVS) Ex- dividend date

CVS Health (NYSE:CVS) is set to go ex-dividend on and will be payable on 5/3/2019


Dividend History for CVS Health (NYSE:CVS)
The next payable dividend for CVS Health is scheduled for 5/3/2019. There is an annual dividend of $$2.00 with a yield of 3.69% The company’s dividend has increased by 12.60% on a 3 Year Average

Recent Dividend History for CVS Health (NYSE:CVS)

  • On 12/13/2012 CVS Health announced a quarterly dividend of $0.2250.
  • On 3/6/2013 CVS Health announced a quarterly dividend of $0.2250.
  • On 7/10/2013 CVS Health announced a quarterly dividend of $0.2250.
  • On 9/25/2013 CVS Health announced a quarterly dividend of $0.2250.
  • On 12/18/2013 CVS Health announced a quarterly dividend of $0.2750.
  • On 3/6/2014 CVS Health announced a quarterly dividend of $0.2750.
Story continues below



About Company
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Specialty, AccordantCare, SilverScript, Wellpartner, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2017, it had 23 retail specialty pharmacy stores, 18 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,803 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 37 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Recent Insider Trading for CVS Health (NYSE:CVS)

  • On 3/1/2019 Edward J Ludwig, Director, bought 4,000 with an average share price of $58.27 per share and the total transaction amounting to $233,080.00.
  • On 3/1/2019 James David Clark, SVP, sold 1,664 with an average share price of $58.14 per share and the total transaction amounting to $96,744.96.
  • On 2/1/2019 Jonathan C Roberts, COO, sold 77,639 with an average share price of $64.54 per share and the total transaction amounting to $5,010,821.06.
  • On 2/1/2019 Larry J Merlo, Insider, sold 166,368 with an average share price of $64.51 per share and the total transaction amounting to $10,732,399.68.
  • On 1/8/2019 Larry J Merlo, Insider, sold 166,368 with an average share price of $69.04 per share and the total transaction amounting to $11,486,046.72.
  • On 11/29/2018 David M Denton, CFO, sold 25,159 with an average share price of $80.13 per share and the total transaction amounting to $2,015,990.67.



Recent Analyst Rating for CVS Health (NYSE:CVS)

  • On 3/6/2019 Citigroup, Lower Price Target, to bought with a price target of $94.00 to $68.00
  • On 2/25/2019 Argus, Lower Price Target, fromBuy to Positive with a price target of $100.00 to $80.00
  • On 2/22/2019 Morgan Stanley, Set Price Target, to bought with a price target of $92.00
  • On 2/21/2019 SunTrust Banks, Lower Price Target, to bought with a price target of $85.00
  • On 2/21/2019 UBS Group, Lower Price Target, fromBuy to Buy with a price target of $75.00 to $74.00
  • On 2/21/2019 Loop Capital, Lower Price Target, fromIn-Line to Hold with a price target of $68.00



Recent Trading for CVS Health (NYSE:CVS)
Shares of CVS Health closed the previous trading session at with 55.01 shares trading hands.

An ad to help with our costs